The transaction will allow the Gujarat-based Zydus to access Agenus's biologics manufacturing facilities in California, US ...

A new report from Pitchbook suggests we’re in for a period of more sustainable investing, with VC firms continuing to create ...

Jefferies has predicted more small tuck-in deals to come, as biotechs struggle to access capital despite key clinical ...

Two boaters were charged with misdemeanor careless boating charges in the May 2024 death of a Ransom Everglades School ...

The medical diagnostics company filed for bankruptcy protection to reorganize its debts, facing high litigation costs.

Recce Pharmaceuticals (ASX:RCE) has successfully filled its coffers ahead of its Phase III clinical trials in Indonesia and ...

In Maine, Mark Ancker became the first person in the U.S. buried in a mushroom casket—an eco-friendly burial alternative ...

CHICAGO -- A single infusion of the chimeric antigen receptor (CAR) T-cell therapy ciltacabtagene autoleucel (cilta-cel; ...

The company hopes to submit its lead drug later this year for FDA approval. What these 3 Bay Area biotech companies did to ...

Protein degradation company Plexium has laid off staff as part of a realignment to support the company’s pipeline, which is ...

By bolstering immune cells, researchers at ViiV Healthcare in Branford have designed long-acting drugs that prevent infection ...

MoonLake Immunotherapeutics' Sonelokimab's Phase 3 trials, PsA market growth, and Merck's $3B bid showcase potential. Read my ...